General Information of Drug (ID: DM9RAYC)

Drug Name
2-(3-Bromo-phenyl)-6-nitro-chromen-4-one
Synonyms CHEMBL64792; 3'-Bromo-6-nitroflavone
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 346.13
Logarithm of the Partition Coefficient (xlogp) 4.5
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C15H8BrNO4
IUPAC Name
2-(3-bromophenyl)-6-nitrochromen-4-one
Canonical SMILES
C1=CC(=CC(=C1)Br)C2=CC(=O)C3=C(O2)C=CC(=C3)[N+](=O)[O-]
InChI
InChI=1S/C15H8BrNO4/c16-10-3-1-2-9(6-10)15-8-13(18)12-7-11(17(19)20)4-5-14(12)21-15/h1-8H
InChIKey
IOYFMBZXVIRMNX-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
9841153
TTD ID
D0Q6CJ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA(A) receptor alpha-1 (GABRA1) TT1MPAY GBRA1_HUMAN Inhibitor [1]
Gamma-aminobutyric acid receptor (GAR) TTNJYV2 NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor, Bioorg. Med. Chem. Lett. 7(15):2003-2008 (1997).